Geron Corp (GERN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current GERN market cap is 2.59B. The company's latest EPS is USD -0.3055 and P/E is -14.01.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 29k | 164k | 23k | 304k | 882k |
| Operating Income | -51.95M | -47.61M | -54.29M | -56.13M | -69.33M |
| Net Income | -49.23M | -44.81M | -51.97M | -55.39M | -67.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 460k | 253k | 1.39M | 596k | 237k |
| Operating Income | -72.7M | -76.91M | -114M | -138.55M | -193.94M |
| Net Income | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 415.3M | 413.02M | 394.08M | 482.07M | 449.4M |
| Total Liabilities | 116.87M | 122.4M | 146.13M | 137.21M | 142.7M |
| Total Equity | 298.43M | 290.61M | 247.95M | 344.87M | 306.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 165.52M | 270.73M | 226.03M | 190.58M | 394.08M |
| Total Liabilities | 30.36M | 59.78M | 99.62M | 110.58M | 146.13M |
| Total Equity | 135.16M | 210.95M | 126.42M | 80M | 247.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.97M | -126.81M | -167.74M | -62.25M | -115.73M |
| Investing | -223.18M | -227.89M | -180.32M | 34.21M | -1.94M |
| Financing | 299.39M | 328.74M | 362.02M | 147.8M | 164.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.9M | -66.65M | -95.56M | -127.38M | -167.74M |
| Investing | 27.4M | -105.32M | 71.95M | 62.07M | -180.32M |
| Financing | 19.57M | 168.35M | 48.56M | 87.26M | 362.02M |
| Market Cap | 2.59B |
| Price to Earnings Ratio | -14.01 |
| Price to Sales Ratio | 10.7k |
| Price to Cash Ratio | 36.83 |
| Price to Book Ratio | 10.41 |
| Dividend Yield | - |
| Shares Outstanding | 602.8M |
| Average Volume (1 week) | 11.31M |
| Average Volume (1 Month) | 8.43M |
| 52 Week Change | 100.93% |
| 52 Week High | 5.34 |
| 52 Week Low | 1.64 |
| Spread (Intraday) | 0.01 (0.23%) |
| Company Name | Geron Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.geron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
